Sangamo Therapeutics Stock Market Value
| SGMO Stock | USD 1.96 0.01 0.51% |
| Symbol | Sangamo |
Sangamo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.24) | Revenue Per Share 0.066 | Quarterly Revenue Growth (0.95) | Return On Assets (0.58) | Return On Equity (1.94) |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sangamo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sangamo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sangamo Therapeutics.
| 12/02/2022 |
| 11/21/2024 |
If you would invest 0.00 in Sangamo Therapeutics on December 2, 2022 and sell it all today you would earn a total of 0.00 from holding Sangamo Therapeutics or generate 0.0% return on investment in Sangamo Therapeutics over 720 days. Sangamo Therapeutics is related to or competes with Editas Medicine, Intellia Therapeutics, Bluebird Bio, and Alnylam Pharmaceuticals. Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicine... More
Sangamo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sangamo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sangamo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.46 | |||
| Information Ratio | 0.1709 | |||
| Maximum Drawdown | 50.57 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 24.14 |
Sangamo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sangamo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sangamo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Sangamo Therapeutics historical prices to predict the future Sangamo Therapeutics' volatility.| Risk Adjusted Performance | 0.1455 | |||
| Jensen Alpha | 1.35 | |||
| Total Risk Alpha | 0.6322 | |||
| Sortino Ratio | 0.2974 | |||
| Treynor Ratio | 0.4038 |
Sangamo Therapeutics Backtested Returns
Sangamo Therapeutics is dangerous given 3 months investment horizon. Sangamo Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.7% are justified by taking the suggested risk. Use Sangamo Therapeutics Coefficient Of Variation of 552.79, semi deviation of 4.54, and Risk Adjusted Performance of 0.1455 to evaluate company specific risk that cannot be diversified away. Sangamo Therapeutics holds a performance score of 13 on a scale of zero to a hundred. The entity has a beta of 4.24, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sangamo Therapeutics will likely underperform. Use Sangamo Therapeutics value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Sangamo Therapeutics.
Auto-correlation | -0.45 |
Modest reverse predictability
Sangamo Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Sangamo Therapeutics time series from 2nd of December 2022 to 27th of November 2023 and 27th of November 2023 to 21st of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sangamo Therapeutics price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Sangamo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
Sangamo Therapeutics lagged returns against current returns
Autocorrelation, which is Sangamo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sangamo Therapeutics' stock expected returns. We can calculate the autocorrelation of Sangamo Therapeutics returns to help us make a trade decision. For example, suppose you find that Sangamo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sangamo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sangamo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sangamo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sangamo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Sangamo Therapeutics Lagged Returns
When evaluating Sangamo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sangamo Therapeutics stock have on its future price. Sangamo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sangamo Therapeutics autocorrelation shows the relationship between Sangamo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Sangamo Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Sangamo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sangamo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Sangamo Stock
Moving against Sangamo Stock
| 0.85 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.83 | PALI | Palisade Bio | PairCorr |
| 0.8 | INZY | Inozyme Pharma | PairCorr |
| 0.74 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.74 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
The ability to find closely correlated positions to Sangamo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sangamo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sangamo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sangamo Therapeutics to buy it.
The correlation of Sangamo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sangamo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sangamo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sangamo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Sangamo Therapeutics Correlation, Sangamo Therapeutics Volatility and Sangamo Therapeutics Alpha and Beta module to complement your research on Sangamo Therapeutics. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Sangamo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.